Risk stratification in the clinical application of minimal residual disease assessment in acute myeloid leukemia.
Zhang C, Gu R, Wang H, Zhou C, Li Y, Liu Y, Wei S, Lin D, Liu K, Fang Q, Gong X, Gong B, Qiu S, Zhang G, Liu B, Wang Y, Mi Y, Wei H, Wang J.
Zhang C, et al. Among authors: gu r.
Cancer. 2024 Nov 10. doi: 10.1002/cncr.35641. Online ahead of print.
Cancer. 2024.
PMID: 39522053